PHODABRA (Dabrafenib) 75mg | Generic BRAF Inhibitor | Pharma 2 Vientiane | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

PHODABRA is a generic dabrafenib produced by Pharma 2 Vientiane, the second state pharmaceutical factory in Vientiane, Laos. It provides the same 75 mg dabrafenib capsule as the originator at a markedly lower price, making BRAF-targeted therapy more accessible. Note that this facility is sometimes flagged online with the word "discontinued"; in fact the plant has completed remediation and is operating normally, with current production available through GLT.

Generic Information: PHODABRA (Dabrafenib)

Pharma 2 Vientiane (State Pharmaceutical Factory No. 2) is one of Laos's principal public-sector drug manufacturers. It produces a range of generic oncology and specialty medicines under Good Manufacturing Practice standards and supplies both the domestic Lao market and export channels. PHODABRA is its dabrafenib offering, named to signal the active molecule while remaining a distinct brand.

What Is PHODABRA (Dabrafenib) Used For?

As a dabrafenib, PHODABRA is for cancers driven by a BRAF V600 mutation: advanced or metastatic melanoma, and — together with trametinib — BRAF V600E-mutated metastatic non-small cell lung cancer and anaplastic thyroid cancer. The active ingredient and its dosing are identical to the originator.

How Does PHODABRA Work?

PHODABRA delivers dabrafenib, which binds the mutated BRAF kinase and shuts down the overactive MAPK signal that BRAF-mutant tumors use to grow. Blocking that pathway slows tumor progression and can trigger cancer-cell death. The generic therefore reproduces the originator's mechanism of action at lower cost.

Indications

  • Unresectable or metastatic BRAF V600-mutant melanoma
  • Adjuvant melanoma therapy with trametinib
  • BRAF V600E metastatic NSCLC with trametinib
  • BRAF V600E anaplastic thyroid cancer with trametinib

Dosage & Administration

The standard dose is 150 mg twice daily, taken as two 75 mg capsules each time, with or without food. Capsules are swallowed whole with water. The 75 mg strength in this listing is the one used to make up the standard dose.

Side Effects

Expect the same side-effect profile as the originator: fever, fatigue, rash, nausea, headache, chills and joint pain are common. Serious risks include new skin cancers, bleeding, heart problems, eye inflammation and high blood sugar. Skin checks and fever monitoring remain important.

Storage & Handling

Keep capsules at room temperature in the original packaging, protected from moisture and light, and out of children's reach. Do not use after the expiry date.

Why Choose PHODABRA?

  • Lower-cost generic — the same dabrafenib at a fraction of the originator price.
  • State-owned Lao manufacturer — Pharma 2 Vientiane with GMP production.
  • Available supply — the plant is operating normally; GLT sources current batches.

How to Order PHODABRA from GLT

  1. Contact GLT via WhatsApp +86 15234153837 or email [email protected] with your required quantity.
  2. Receive a quotation and delivery schedule.
  3. Complete payment via Hao Yi Lian / 好易联.
  4. Shipment dispatches with documentation and tracking.

A valid prescription may be requested before dispatch. We serve institutions and individual patients.

FAQ

1. Is PHODABRA still available?

Yes. The Lao Pharma 2 plant has completed remediation and is producing normally; GLT supplies current batches of PHODABRA.

2. Is PHODABRA the same as Tafinlar?

It is a generic containing the same 75 mg dabrafenib active ingredient, manufactured by a different company.

3. Do I need a prescription?

Yes, dabrafenib requires a prescription, which may be requested before dispatch.

Related Oncology Products

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...

Rizonib (Crizotinib) 250mg Capsules | DIL Bangladesh Generic Xalkori for ALK+ NSCLC | GLT

Rizonib 250 by Drug International Ltd (DIL), Tongi Gazipur — affordable crizotinib generic from Bangladesh

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...